Abstract
In 2007, the U.S. market for interventional cardiology devices was valued at
almost $5 billion, experiencing a small increase over 2006. Drug-eluting
stents were the largest segment of the market, followed by coronary closure
devices, percutaneous transluminal coronary angioplasty (PTCA) balloons,
bare-metal stents, embolic protection devices, interventional guidewires,
diagnostic catheters, intravascular ultrasound (IVUS) catheters, and
interventional catheters, as depicted in Chart 1-1. From 2007, the U.S. market
for interventional cardiology is expected to decrease, with the market limited
by the safety concerns over drug-eluting stents.
View Cart
